【ChiCTR1800015126】Effects of immersive virtual reality intervention on pain and anxiety among paediatric cancer patients undergoing peripheral intravenous cannulation: A randomized controlled trial
ChiCTR1800015126
正在进行
/
/
/
2018-03-09
/
/
癌症
Effects of immersive virtual reality intervention on pain and anxiety among paediatric cancer patients undergoing peripheral intravenous cannulation: A randomized controlled trial
Effects of immersive virtual reality intervention on pain and anxiety among paediatric cancer patients undergoing peripheral intravenous cannulation: A randomized controlled trial
999077
This study aims to assess the effects of immersive virtual reality as a distraction intervention to reduce pain and anxiety among paediatric cancer patients undergoing peripheral intravenous catheter insertion.
随机平行对照
探索性研究/预试验
Paediatric cancer patients will be randomly assigned to one group or the other. Serially numbered opaque sealed envelopes containing the grouping identifier (control or intervention) will be prepared in advance by an independent statistician using computer-generated random number sequences.
/
NA
/
30
/
2017-09-13
2018-08-31
/
Inclusion criteria: Patients who are (1) aged between 7 and 18; (2) scheduled to undergo peripheral intravenous catheter insertion; (3) can understand Chinese.；
请登录查看Exclusion criteria: Patients who have (1) identified cognitive and learning problems in their medical record; (2) have brain tumors or metastasis; (3) contact precaution; (4) have history of seizures and motion sickness.；
请登录查看NA
999077
NA的其他临床试验
- 磷酸奥司他韦颗粒在健康参与者中空腹与餐后条件下开放、随机、单次给药、两制剂、两序列、两周期交叉设计生物等效性试验
- Effects of virtual reality intervention on pain and anxiety among paediatric patients undergoing nasopharyngeal swab in emergency department: A randomized controlled trial
- 一种阴道凝胶治疗女性生殖道HPV感染及相关疾病的临床疗效观察及研究
- Effects of immersive virtual reality intervention on pain and anxiety among paediatric cancer patients undergoing peripheral intravenous cannulation: A randomized controlled trial
- 改变饮食习惯有助于预防儿童肥胖：9年队列研究证据，基于既往资料的研究
香港中文大學的其他临床试验
- Feasibility, Acceptability and Effectiveness of a Tailored Multidimensional Intervention for Dementia Family Caregivers in Caregiving and Mental Health Crisis: A Pilot Randomised Controlled Trial
- One-step Rehydration Thawing Method in Frozen Embryo Transfer: A pragmatic randomized controlled clinical trial (ORT-FET-RCT)
- 以環孢素眼藥水作為一線治療「非乾燥症而血清因子陽性的水液缺乏型乾眼症」的多中心隨機對照試驗
- 動作協調障礙兒童體育課中的內隱動作學習
- Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial
- 一項前瞻性、單組介入研究：評估不含防腐劑交聯透明質酸和蘆薈眼藥水於白內障術後乾眼的療效
- 运动与脑刺激疗愈：促进居住于分间楼宇单位的注意力缺陷多动障碍儿童症状控制的三臂随机对照试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- 混合實境及沉浸式的神經認知眼科診斷 (MIND) 平台
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- 青光眼中圖樣視網膜電圖之結構與功能整合
- 一种用于糖尿病视网膜病变定量病灶评估的眼动追踪注意感知强化学习算法
- 甲狀腺眼病患者外周免疫細胞譜
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- 瞼板腺功能障礙的代謝組學研究
- Dissecting the role of gut microbiota in primary glaucoma patients through case-control and longitudinal cohort study
- 以理論為基礎的跨專業教育計劃，以提高香港華人社區長者的新冠疫苗接種率
- 復發性眼部單純疱疹病毒疾病患者的生活質素與病人自述結果：一項前瞻性橫斷面研究
- 正常眼壓青光眼疑似個案及視野缺損早期患者之眼壓藥物調整研究
- 使用生理和藥理方法調整眼瞼局部麻醉劑以改善手術止血效果和痛楚水平：雙盲隨機對照試驗
最新临床资讯
-
诺华：CFB抑制剂终止狼疮肾炎二期临床
医药笔记2026-10-17
-
泽安生物医药：实体瘤MCE启动一期临床
医药笔记2026-10-17
-
药明康德2026-10-17
-
沃森生物2026-10-16
-
罕见病信息网2026-10-16
-
武警特色医学中心2026-10-16
-
生物经纬2026-10-16
-
良医汇肿瘤资讯2026-10-16
-
BioMed科技2026-10-16
-
蒲公英资讯2026-10-16
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-10-28
-
2026-10-28
-
2026-10-28
-
摩熵咨询 33 54
-
摩熵咨询 20 3
-
摩熵咨询 20 10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
-
颁布机构：国家药品监督管理局药品审评中心 2026-09-28
-
颁布机构：国家药品监督管理局 2026-09-10
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-10-26
-
2026-10-23
-
2026-10-23
-
摩熵咨询 35 83
-
摩熵咨询 28 71
-
摩熵咨询 34 47
-
颁布机构：国家药品审评中心（CDE） 2026-10-23
-
颁布机构：国家药品监督管理局 2026-10-19
-
颁布机构：国家市场监督管理总局 2026-10-16